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During the assembly process of herpes simplex virus type 1 capsids, there is an essential interaction between the
C-terminal tail of the scaffold proteins (22a and 21) and the major capsid protein (VP5). Recent studies of spontaneous
revertant viruses that overcome a blocked maturation cleavage site of the scaffold proteins have shown that the N-terminus
of VP5 is important for this interaction. One of the revertant viruses, PR7, encodes a second-site mutation at residue 69 of
VP5 which unlike wild-type VP5 fails to interact with 22a and thus gives white colonies in the yeast two-hybrid assay. In the
present study a small DNA fragment, encoding residues 1 to 85 of wild-type and PR7 VP5, was mutagenized using
error-prone PCR. Mutagenized DNA was used in the yeast two-hybrid assay to identify mutations in wild-type VP5 that
resulted in loss of 22a binding (white colonies), or in PR7 VP5 that resulted in a gain of function (blue colonies). For the loss
of function experiments, using KOS VP5, a row of eight thymidine nucleotides (codons 37–40) resulted in many frameshift
mutations, which led us to terminate the study without reaching a statistically significant result. For the PR7 experiment, 30
clones were identified that had single amino acid substitutions, and these mutations were localized to amino acids 27–45 and
63–84 of VP5. The most frequent mutation was a reversion back to wild-type. The next most frequent were E28K and N63S,
and these gave the highest b-galactosidase enzyme activities (indicative of PR7VP5-22a interaction), 30 and 20% of wild-type,
respectively. When E28K and N63S were transferred into the wild-type VP5 background, that is, in the absence of the PR7
mutation, they gave rise to different phenotypes. The E28K mutation lost its ability to interact with the scaffold proteins as
judged by this assay. Therefore, it may be acting as a compensatory mutation whose phenotype is only expressed in the
presence of the original PR7 mutation. However, the N63S mutation in the wild-type VP5 background increased the
interaction, as judged by the b-galactosidase activity, by a factor of 9 relative to when the PR7 mutation was present. Even
more surprising, in the absence of the PR7 mutation the enzyme activity was still greater, by a factor of 2, than that observed
for wild-type VP5. This study provides further evidence that the N-terminus of VP5 is in intimate association with the
C-terminus of the scaffold proteins. © 2001 Academic Press
Key Words: herpesvirus; capsid assembly; VP5; scaffold proteins; yeast two-hybrid; protein–protein interactions.
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1INTRODUCTION
Essential for the assembly of the herpes simplex virus
type 1 (HSV-1) virion is the construction of an icosahedral
capsid that encloses the genome. The capsid shell com-
prises four proteins, VP5, VP19C, VP23, and VP26 (Cohen
et al., 1980; Gibson and Roizman, 1972; Heilman et al.,
979). During the capsid maturation process, the scaffold
roteins (22a and 21) occupy the internal space of the
apsid. The shell achieves icosahedral symmetry due to
he presence of these scaffold proteins (Desai et al.,
994; Tatman et al., 1994; Thomsen et al., 1994). Cleav-
ge of the scaffold proteins at the maturation site by the
iral encoded protease (VP24) (DiIanni et al., 1993; Liu
nd Roizman, 1991; Preston et al., 1992) results in the
oss of 22a and 21 from the interior of the capsid. This
pace is subsequently occupied by the viral genome.
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308rotein–protein interactions drive the assembly of the
apsid structure. A critical interaction between the scaf-
old protein 22a, and the major capsid protein, VP5 (De-
ai and Person, 1996), was detected in our laboratory
sing the yeast two-hybrid system (Fields and Song,
989).
Several studies have shown that the 25 C-terminal
mino acids of the scaffold protein are necessary and
ufficient for the interaction with VP5 (Desai and Person,
996; Hong et al., 1996; Kennard et al., 1995; Oien et al.,
997; Thomsen et al., 1995). Recent reports (Desai and
Person, 1999; Warner et al., 2000) have identified a small
region at the N-terminus of VP5 as being critical for its
interaction with 22a. These studies utilized a virus in
which the maturation cleavage site in the scaffold pro-
teins was blocked by mutation (Person and Desai, 1998).
This mutation was lethal since it prevented the release of
the scaffold molecules from the capsid structure and
thus these capsids fail to acquire a genome. However,
spontaneous revertants of this mutant virus were readily
isolated on noncomplementing cells. These revertants
were second-site mutants and subsequent mapping and
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309MUTATIONS IN VP5 OF HSV-1sequence analysis revealed the majority (21 out of 33) of
these mutations to be localized at the N-terminus of VP5,
between residues 30 and 80. The mutants were in two 12
amino acid stretches and five were at amino acid 34 and
10 at amino acid 78 (Warner et al., 2000). These second-
ite mutations are suggested to act by weakening the
nteraction between VP5 and 22a once the capsid has
ormed, thereby allowing the release of the scaffold pro-
eins from the maturing capsid in the absence of cleav-
ge.
The goal of this study was to identify key residues in
he N-terminus of VP5 that may directly interact with the
caffold proteins. Residues 34 and 78 of VP5 were found
o be important for this interaction, using a genetic anal-
sis of revertant viruses (Warner et al., 2000). It seemed
hat a different approach might uncover other key resi-
ues. In the present study a 255-nucleotide fragment
ncoding the N-terminus of VP5 was subjected to ran-
om, saturation mutagenesis using error-prone PCR, and
he mutants were analyzed using the yeast two-hybrid
ssay. Templates for the mutagenesis were DNA frag-
ents encoding the N-terminus of wild-type VP5 and a
evertant virus, PR7. A mutation in PR7 encoding residue
9 of VP5 allows it to overcome a block in the maturation
leavage site of the scaffold proteins. PR7 VP5, when
sed with scaffold proteins in the two-hybrid assay, gives
hite colonies unlike wild-type VP5, which gives blue
olonies. Using these two templates, mutagenized plas-
ids were used in the two-hybrid assay to monitor mu-
ations in the wild-type plasmid for loss of function (white
r pale blue colonies) and PR7 mutant plasmids for gain
f function (dark blue colonies).
RESULTS
andom mutagenesis of the N-terminus of the UL19
VP5) gene
In the yeast two-hybrid system (Fields and Song, 1989)
he yeast transcriptional activator, Gal4, consists of a
NA binding domain (residues 1–147) and a transcrip-
ional activation domain (residues 768–881) that are dis-
inct and separable. Fields and his colleagues showed
hat weak interactions between proteins fused to each
omain can result in transcription and translation of a
b-galactosidase indicator gene fused to a Gal4-respon-
sive promoter giving rise to blue yeast colonies in the
presence of the chromogenic substrate, X-gal. Blue col-
onies are also formed when VP5 is fused to the DNA
binding domain and 22a is fused to the transactivation
domain (Desai and Person, 1996).
For the present experiments error-prone PCR mu-
tagenesis of a small (255-nucleotide) fragment encoding
the N-terminus of VP5 (codons 1 to 85) was performed.
The resulting mutagenized fragments were transferred
into the yeast two-hybrid vector that encodes the whole
VP5 open reading frame (ORF), replacing the wild-typesequence between codons 1 to 85 with mutant se-
quences. To test the feasibility of this assay, the initial
PCR mutagenesis experiment utilized a Mn:Mg ratio of
1:4 (MnSO4 5 0.5 mM, MgCl2 5 2 mM). Based on the
experiments of Svetlow and Cooper (1998), it seemed
that this ratio may produce approximately one mutation
per molecule amplified. In their experiments a 100-bp
fragment was amplified using a 1:3 ratio of Mn:Mg with
the result that 25% of the clones had single mutations
and 15% had double mutations. In the first experiment the
255-nucleotide fragment was amplified in the presence
or absence of MnSO4 and the fragments ligated into the
yeast plasmid encoding VP5 fused to the Gal4 DNA
binding domain. Bacteria transformed with these liga-
tions were amplified and DNA was extracted. This DNA
was then cotransformed into yeast cells together with
DNA encoding the scaffold protein, which was fused to
the Gal4 transactivation domain. The wild-type plasmid
expressing VP5 was used as a positive control. Approx-
imately 200 transformants per plate were obtained and
they were examined for b-galactosidase enzyme activity
sing the X-gal colony color assay. All of the colonies
ave similar kinetics of color development (blue color) for
NA that did not employ PCR and DNA amplified in the
bsence of MnSO4. When DNA amplified in the presence
MnSO4 was used, about one colony in five did not turn
blue in the time it took for full-color development of
untreated DNA, usually a few hours. This experiment
showed it was feasible to identify mutants that affect the
interaction of VP5 with the scaffold proteins.
The next step was to determine the frequency and
distribution of the mutations generated by error-prone
PCR mutagenesis of the N-terminal 255 nucleotide frag-
ment of UL19 (VP5), using a Mn:Mg ratio of 1:4. To do
this, DNA was isolated from 10 bacterial colonies, the
DNA was sequenced, and a total of 15 base changes
were detected (1.5 mutants per clone). Two clones had
no changes; four clones had one mutation, and the
remaining four clones had more than one mutation.
Eleven of these 15 mutations resulted in amino acid
substitutions; the other four (or 27%) were silent (see Fig.
1). Thirteen of the mutations were transitions and only
two were transversions (13%). DNA from the four individ-
ual bacterial clones that had a single coding change per
molecule, and from three that had two coding changes
per molecule, were used to cotransform yeast together
with DNA encoding the scaffold protein fused to the Gal4
transactivation domain. Colonies that formed on a single
plate were examined using the X-gal filter assay
(Breeden and Nasymth, 1985). All of the colonies for the
mutants that had single changes were blue and all of the
colonies from the plate of the mutants with two changes
were white.
A Mn:Mg ratio of 1:4 gave 1.5 base changes per mol-
ecule and the same number of molecules with a single
base change (four) and with more than one base change
nt with
310 WARNER ET AL.(four). Therefore, to decrease the number of molecules
with multiple mutations, the Mn:Mg concentration was
decreased to 1:8 and 1:16 and DNA sequence analysis of
bacterial clones gave a frequency of 0.22 and 0 muta-
tions per molecule, respectively. The concentration of
Mn:Mg of 1:8 was used for the experiments with KOS
VP5 described in the next section. Data are shown in Fig.
1 for the distribution of mutations throughout the DNA
fragment amplified and includes the sequence analysis
of clones from additional experiments. The mutants gen-
erated by the PCR amplification are distributed through-
out the fragment.
PCR mutagenesis of wild-type (KOS) VP5
In the experiment using wild-type (KOS) VP5 as a
template, yeast colonies that arose following cotransfor-
mation of SFY526 that were white, a faint blue or light
blue as judged by the X-gal filter assay, indicative of a
loss or reduction of the interaction between VP5 and 22a,
were picked. The mutagenesis of wild-type (KOS) VP5
FIG. 1. Location of the residue changes in the N-terminal portion o
sequence of VP5 spanning from residue 8 to 85 is shown. Shown below
with the mutagenized plasmids. Random clones from each mutagen
compiled from three experiments with wild-type VP5 and one experime
but it was silent.
T
Single Mutations in Wild-Type (KOS) VP5 that Reduced
as Measured by the
Number of mutants Codon altered DNA ch
1 31 TCG3
1 33 CGA3
6 39 T T T3
1 55 GAC3
1 62 TGC3
1 66 TCG3
1 79 TGC3Note. Only one representative of the mutation at codon 39 was tested. NDgave 29 mutant clones that displayed this phenotype.
When the plasmid inserts of VP5 were sequenced, 19
had a mutation in a stretch of eight thymidines from
amino acid 37 to 40 that resulted either in a deletion and
consequently a frameshift (21) for the downstream se-
quence (13 clones) or in a TTT3 TAT change at residue
39 (six clones). Another clone had a mutation at residue
33 that changed an Arg to a stop codon and caused early
termination (Table 1). Four other clones had more than
one mutation and were discarded from further analysis.
The other mutants were distributed between residues 31
and 79. The 12 clones that had single mutations and
result in a reduction in the interaction with 22a when
assayed quantitatively are shown in Table 1. Six of these
were mutated at residue F39Y; the others were at resi-
dues S31L, D55G, C62R, S66P, and C79R. The results of
the quantitative b-galactosidase assay showed that most
of these mutations had less than 1% of the wild-type
activity. The only exception was the change at residue 55
(7.7% activity of wild-type). Because of the large number
enerated by random error-prone PCR mutagenesis. The amino acid
quence are the mutations identified following transformation of E. coli
xperiment were analyzed by sequencing. The mutations shown are
PR7 VP5. The * indicates that there was a base change in this codon,
inated the Interaction with the Scaffold Protein (22a)
Two-Hybrid Assay
Amino acid change
b-galactosidase activity
(% of wild-type)
S3 L 0.7
R3 OPA ND
F3 Y 1.0
D3 G 7.7
C3 R 0.7
S3 P 0.3
C3 R 0.6f VP5 g
the se
esis eABLE 1
or Elim
Yeast
ange
TTG
TGA
TAT
GGC
CGC
CCG
CGC, not determined.
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311MUTATIONS IN VP5 OF HSV-1of frameshift mutations between amino acids 37 and 40,
it was decided not to pursue the loss of function studies
further. Repeated nucleotides are sites for frameshift of
61, as was first suggested by Streisinger et al. (1966).
PCR mutagenesis of PR7 VP5
Following cotransformation of yeast with DNA encod-
ing the scaffold protein fused to the Gal4 transactivation
domain and DNA encoding VP5 of PR7 fused to the Gal4
DNA binding domain, the resulting transformants give
rise to white colonies in the b-galactosidase filter assay.
CR mutagenesis of the same 255-nucleotide fragment
erived from PR7 could lead to colonies that develop a
lue color indicative of interaction. Unlike the experi-
ents using KOS DNA where the assay was for a loss or
ecrease of enzyme activity, for the PR7 DNA, the assay
as for an increase of activity. In this case one is scoring
or the gain as opposed to the loss of function. The fact
hat PR7 produces white colonies makes these experi-
ents more tractable.
The error-prone PCR mutagenesis of PR7 VP5 was
arried out using a Mn:Mg ratio of 1:4 in the reaction
uffer. Following transformation of yeast, 37 blue colo-
ies were selected. Seven clones were discarded from
his analysis because they had multiple mutations. The
emaining 30 clones had single mutations in the mu-
agenized portion of UL19 and are summarized in Table
. The most frequent mutation (10 out of 30) detected was
reversion of the original PR7 mutation back to wild-type
C69R). This mutation restored the activity of b-galacto-
idase back to the wild-type level. The next most com-
TABLE 2
Single Mutations in VP5 of PR7 that Partially or Totally Restored the
Interaction with the Scaffold Protein (22a) as Measured by the Yeast
Two-Hybrid Assay
Number of
mutants
Codon
altered DNA change
Amino acid
change
b-galactosidase
activity (% of
wild-type)
1 27 ATC3 ACC I3 T 11.4 6 1.4
6 28 GAG3 AAG E3 K 29.6 6 3.9
1 29 GTG3 GAG V3 E 10.4 6 4.0
2 39 T T T3 CTT F3 L 4.6 6 1.2
1 43 CGC3 AGC R3 S 2.8 6 2.4
1 45 GAT3 GGT D3 G 3.2 6 0.5
6 63 AAC3 AGC N3 S 19.5 6 4.8
10 69a TGC3 CGC C3 R 97.3 6 17.2
2 84 T T T3 TCT F3 S 3.0 6 0.6
Note. Only one representative of each mutation at the different
odons was tested.
a The original PR7 mutation in VP5 was R3 C at residue 69, and the
b-galactosidase activity was 0.8 6 0.02% of wild-type. All the mutants
at this residue are revertants back to the wild-type.on mutations isolated were two separate mutations
ach isolated six times: residue E28K and residue N63S.he mutation at residue 28 restored the interaction as
easured by the b-galactosidase activity assay to al-
ost one-third of wild-type (approximately 30%), while
he mutation at residue 63 restored the activity to approx-
mately 20% of the wild-type level. Mutations at the other
esidues were isolated less frequently (Table 2) and the
b-galactosidase activity detected for these mutants was
3 to 10% of the wild-type level. A mutation at residue 39
was isolated in both PR7 (F39L) and KOS (F39Y) VP5.
This is the only example of a residue mutated in both VP5
proteins. The mutations have different phenotypes. In
PR7 the mutation increased the level of enzyme activity
detected, whereas in KOS the mutation decreased the
enzyme activity significantly. This was probably due to
the specific change created at the residue and also the
context of the mutation, that is, in PR7 or wild-type pro-
teins.
Introduction of mutations at residues 28 and 63 into
wild-type VP5
The mutations E28K and N63S gave the highest en-
zyme activity in the presence of the PR7 mutation (R69C).
Discounting the reversion to wild-type sequence at res-
idue 69 (C69R), the mutations at residue 28 and 63
represent 12 of the remaining 20 clones tested and were
the most frequent changes observed. These mutations
may compensate for the PR7 mutation in this assay by
interacting directly or indirectly with 22a or the amino
acid change may enhance the interaction of the PR7 VP5
protein. To determine their activities in the absence of
the PR7 mutation, the same changes were introduced
in wild-type VP5 at residues 28 (GAG 3 AAG) and 63
(AAC 3 AGC) by site-directed mutagenesis. These con-
structs were introduced into yeast cells together with
DNA encoding the scaffold proteins and tested for the
ability of the expressed proteins to interact. The substi-
tution of S for N at residue 63 resulted in the faster
appearance of blue staining colonies compared to wild-
type. In addition the level of b-galactosidase activity (see
Table 3) detected was increased by ninefold relative to
that observed in the PR7 background (compare rows 4
and 5) and by nearly twofold to that observed for wild-
type VP5. Therefore, this mutation does enhance the
TABLE 3
Mutations at Residues 28 (E28K) and 63 (N63S) in the
Presence and Absence of the PR7 R69C Mutation
Mutant
b-galactosidase activity
(% of wild-type)
PR7 R69C 0.32 6 0.26
E28K/PR7 35.5 6 9.5
E28K/KOS 0.46 6 0.06
N63S/PR7 19.3 6 0.57
N63S/KOS 174.2 6 53.4
312 WARNER ET AL.interaction; in fact it is able to better interact with 22a
than the wild-type protein. The substitution of K for E at
residue 28 in KOS VP5 produced yeast colonies that did
not turn blue in contrast to the same mutation in PR7 VP5
which produced colonies that turned dark blue quickly.
The enzyme activity was reduced by 70-fold in KOS
compared to PR7 (Table 3, compare rows 2 and 3) and by
200-fold compared to wild-type. Thus this mutant did not
enhance interaction of wild-type VP5 with 22a, and the 28
mutation acts like a true compensatory mutation, in that
it increased the enzyme activity only in the presence of
the PR7 mutation.
DISCUSSION
The molecular interaction between the scaffold protein
(22a) and the major capsid protein (VP5) of HSV-1 was
initially studied by the introduction of random mutations
in the N-terminus of KOS VP5 using error-prone PCR
mutagenesis. Mutagenized fragments were used to re-
place the same region of the wild-type VP5 and the
resulting plasmids encoding an intact VP5 gene were
introduced into the yeast two-hybrid assay along with a
plasmid encoding wild-type scaffold protein. Mutations
generated in KOS VP5 that resulted in a decrease in the
intensity or absence of blue color of the yeast colonies,
indicating a loss of functional interaction with 22a, were
picked. Sequence analysis revealed six mutations that
each occurred once and were at residues 31, 33, 55, 62,
66, and 79. All of the mutations result in enzyme activities
of less than 1% of the wild-type value except for the
change at residue 55, which was 7.7%. The original
colonies we picked using a visual screen tends to select
for colonies that are light blue or white and prejudices
the results toward mutants that have a low level of
enzyme activity. The remaining 19 clones were localized
to a row of eight thymidines encoding codons 37 to 40
and included 13 frameshift mutations. The occurrence of
frameshift mutations in repetitive sequence has been
shown to occur for normal DNA polymerases due to
slippage of the template or primer strand during its
replication (Striesinger et al., 1966). This can result in
deletion or insertion of nucleotides causing a frameshift.
Mutations in this region were not evident when randomly
selected clones were isolated from bacteria (see Fig. 1).
They only became apparent and more frequent when
selection was used to screen the yeast transformants.
The high frequency of these mutations precluded a sta-
tistically significant analysis of the KOS mutations. Al-
though it is possible to redo these experiments and
avoid the frameshift problem by selecting for dark blue
colonies, we decided not to pursue these experiments
since the probability of picking clones that do not have a
mutation would be increased. Furthermore, the experi-
ments to study the mutations that result in gain of func-
tion using PR7 DNA proved to be more productive. Theoccurrence of six mutations at residue 39 (F39Y) in wild-
type VP5 which result from a TTT to TAT change rather
than the deletion mutations seen in this region is tanta-
lizing. This mutation significantly reduced the enzyme
activity compared to wild-type. It is possible that the
repeat sequence affects the fidelity of the polymerase
and hence the high number of mutations at residue 39.
However, the observation that in the PR7 experiment this
residue was also mutated albeit to another hydrophobic
residue (F39L) suggests that this phenylalanine may be a
key residue for binding to 22a.
Following mutagenesis of VP5 of PR7, a total of 37
clones were selected for further analysis. DNA sequenc-
ing showed that seven of these had multiple mutations
and were not examined further. Of the remaining 30, 10
regained the wild-type enzyme activity by reverting to the
wild-type codon at residue 69; that is, the original PR7
mutation was changed to wild-type (C69R). The mutant
resulted from an AT to GC transition (coding strand
nucleotides are underlined). Although these mutations
have to occur in a mutagenesis experiment, they do
increase the background of an uninteresting mutant. The
remaining 20 included two mutants that each occurred
six times, E28K and N63S. These were detected in inde-
pendent mutagenesis experiments so they could not be
sisters. They also had the highest enzyme activities of
any of the other mutants (30 and 20% of wild-type). The
distribution of the PR7 mutants which are localized to
regions 27 to 45 and 63 to 84 are shown in Fig. 2 along
with the locations of the mutations detected in the rever-
tant viruses from the earlier studies (shown above the
protein sequence) which are localized to similar but
smaller regions, from residues 30 to 41 and 69 to 80. Of
the yeast mutations in the PR7 study, five out of the nine
were in residues conserved in the alphaherpesviruses
(underlined residues in Fig. 2). No mutations were found
in the residues that were absolutely conserved in all
herpesviruses. The remaining mutations were in noncon-
served codons. Interestingly, the residue at 63 (aspara-
gine) is conserved in members of all three herpesvirus
families except in pseudorabiesvirus where it is a serine
similar to the mutation analyzed. The PR7 mutation, un-
like the other PR mutations tested in this assay, for
example, PR5 (residue 34) and PR6 (residue 78), gave
white colonies in the filter assay (Desai and Person,
1999). This made it possible to select for the gain of
interaction mutations using a colony color change assay.
These experiments revealed two residues that have
interesting and maybe important roles in this interaction.
The mutation E28K increased the interaction with 22a in
the presence of the R69C (PR7) mutant but in the wild-
type protein gave no detectable interaction. It appears to
compensate for the PR7 mutation, although the mecha-
nism by which it does this is not clear. The N63S muta-
tion behaves very differently in the absence of the PR7
mutation. In the KOS or wild-type background it en-
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313MUTATIONS IN VP5 OF HSV-1hances the interaction between these proteins. It inter-
acts better than the wild-type protein and this may indi-
cate that this residue is important for binding to 22a. The
PR7 mutation (R69C) is a particularly debilitative muta-
tion. It results in a temperature-sensitive phenotype in
virus and the absence of a detectable interaction of this
protein with 22a in the yeast two-hybrid assay (Warner et
al., 2000). The PR7 VP5 molecule may have trouble fold-
ing into the correct conformation under restrictive con-
ditions (high temperature or fused to the Gal4 protein). If
that is the case in the yeast system, then some of the
mutations detected in PR7 VP5 that result in gain of
interaction may be exerting their effects by compensat-
ing for this defect. This appears to be case for the E28K
mutation. It would be interesting to transfer these muta-
tions into the virus (PR7) to determine whether they can
overcome the temperature-sensitive phenotype and how
they affect the ability of the protein to free itself from the
interaction with the scaffold proteins.
It has been shown that the C-terminal 25 amino acids
of the scaffold protein 22a are sufficient for the interac-
FIG. 2. Location of the mutations in the N-terminal portion of VP5.
he amino acid sequence of VP5 (strain KOS) from residue 27 to 45 and
3 to 85 is shown. Illustrated above the sequence are the mutations
dentified in the revertant viruses that overcome the blocked maturation
leavage site in the scaffold proteins. Shown below the sequence are
he mutations in PR7 which were selected for their ability to restore
ome or all of the wild-type b-galactosidase activity. The PR7 mutation
is at residue 69 (R3 C). Residues that are in bold are conserved in all
herpes viruses examined (herpes simplex type 1 (HSV-1) and type 2
(HSV-2), pseudorabies virus (PRV), equine herpesvirus-1 (EHV-1), bo-
vine herpesvirus 1 (BHV1), varicella-zoster virus (VZV), turkey herpes-
virus 2 (THV-2), human herpesvirus 8 (HHV8), equine herpesvirus-2
(EHV-2), Epstein–Barr virus (EBV), murine herpesvirus 68 (MHV68),
Alcelaphine herpesvirus 1 (Ahv1), human herpesvirus 6 (HHV6), human
herpesvirus 7 (HHV7), human cytomegalovirus (HCMV), simian cyto-
megalovirus (SCMV), and murine cytomegalovirus (MCMV)). The resi-
dues that are underlined are conserved in the alpha herpesviruses
(HSV-1, HSV-2, PRV, EHV-1, BHV1, THV-2, and VZV).tion with VP5 (Desai and Person, 1996; Hong et al., 1996;
Kennard et al., 1995; Oien et al., 1997; Thomsen et al.,
m
a995). The elegant studies of Hong and colleagues dem-
nstrated that the interaction between these two pro-
eins is hydrophobic in nature. Furthermore, they showed
hat an amphipathic helix was essential for the interac-
ion. The hydrophobic phenylalanine at residue 39 which
as mutated both in the KOS and in the PR7 experiments
nd other hydrophobic residues in this region may di-
ectly interact with the hydrophobic residues of the C-
erminus of 22a (Hong et al., 1996). The KOS F39Y mu-
ation results in a loss of hydrophobicity and conse-
uently loss of function, whereas the PR7 F39L mutation
etains the hydrophobic nature of the side chain and
esults in an increase in 22a binding. Using the Sweet/
isenberg hydrophobicity protein tool box (Sweet and
isenberg, 1983), a hydrophobicity plot of the N-terminus
f VP5 reveals two regions spanning residues 31–41 and
2–89 that are hydrophobic. Within this region are two
bsolutely conserved phenylalanines (F36 and F70, see
ig. 2) which could also be important for binding to the
-terminus of 22a.
Normally in wild-type virus the scaffold proteins are
eleased by cleavage at the maturation cleavage site of
he scaffold proteins. When this site is blocked by muta-
ion, a lethal phenotype is observed (Person and Desai,
998). The spontaneous revertants that arise can over-
ome the lethal effect presumably by weakening the
nteraction with the scaffold proteins once the capsid is
ormed so that they can exit this structure. Nevertheless,
he initial interaction between VP5 of the revertant vi-
uses and 22a is important for the production of a scaf-
old/shell structure. One of the striking observations from
his study was that none of the mutations identified in
his paper were in the residues in which the second-site
utations were mapped (see Fig. 2). This is probably
ecause the nature of these two mutations is quite dif-
erent even though they both affect the interaction with
2a. The residues of VP5 that are changed in the rever-
ant viruses probably do not directly interact with the
caffold proteins. Rather they may surround those resi-
ues that are in direct contact with 22a.
One corollary to these studies is how the mutations
ffect the folding of the VP5 molecule in this region. The
utations could have global effects on secondary struc-
ure, which disrupt protein interactions. For that reason
he mutations detected in PR7 may be more informative.
lthough not much is known about the secondary struc-
ure in this region, cryoelectron microscopy of the capsid
as revealed that there are two long alpha helices in the
egion of VP5 that is closest to the interior of the capsid,
hich is presumably the region that interacts with the
caffold proteins (Zhou et al., 2000). The second-site
evertants from the previous studies were located in an
lpha helix and a beta sheet conformation of the protein
s predicted using a computer-generated program. The
ajority of the mutations from the PR7 experiment are
lso located in the two alpha helices, spanning residues
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314 WARNER ET AL.22–42 and residues 58–72. In an earlier paper, Zhou and
colleagues compared the structure of the B capsid con-
taining cleaved scaffold proteins and a protease-minus
capsid from recombinant baculovirus-infected cells in
which the scaffold proteins were not cleaved (Zhou et al.,
998). A comparison of these two structures revealed
xtra density attached to the underside of the capsid
hell in the protease-minus capsid. The authors con-
luded that the extra density was due to the attachment
f the C-terminus of 22a to the capsid shell and the
ocation of this attachment was shown to be underneath
he triplex proteins. This would also suggest that the
-terminus of VP5 is close to these positions in the shell.
We now have data from both the genetic analysis of
irus mutants and an in vitro protein–protein interaction
ssay (Fields and Song, 1989) that reinforce the impor-
ance of the N-terminus of VP5 for the interaction with the
caffold molecules. The present study was aided by the
nalysis of the second-site mutations in VP5, which per-
itted us to concentrate our mutagenesis efforts on a
mall region of this large polypeptide. The majority of the
econd-site mutations in the revertant viruses were clus-
ered in two main areas between residues 30 and 41 and
rom 69 to 80 (see Fig. 2); in fact the residues at 34 and
8 are particularly important for this phenotype (Warner
t al., 2000). The analysis of the mutations in the N-
erminal 85 amino acids of VP5 in this paper shows that
hese changes affect the interaction between 22a and
P5. The data from this study and those of the previous
tudies further implicate the N-terminus of this large
rotein as being important for this bimolecular interac-
ion.
MATERIALS AND METHODS
lasmids
Plasmids pGBT9 and pGAD424 were kind gifts from
tanley Fields (Fields and Song, 1989). pGBT9-VP5 con-
ains the VP5 open reading frame fused to the Gal4 DNA
inding domain and pGAD424–22a contains the 22a ORF
used to the Gal4 transactivation domain (Desai and
erson, 1996). VP5 and 22a are encoded by HSV-1 genes
L19 and UL26.5, respectively (McGeoch et al., 1988).
pGBT9-PR7 contains the VP5 ORF from the revertant
virus PR7. The mutation in PR7 was R69C (Desai and
Person, 1999).
The yeast cell line SFY526 was a kind gift from Stanley
Fields (Fields and Song, 1989). This cell line carries a
lacZ reporter gene under the control of Gal4 binding
sites. SFY526 is also auxotrophic for trp and leu. These
two genetic markers are provided by the cotransforming
plasmids pGBT9 (TRP1) and pGAD424 (LEU2).
Random PCR mutagenesisA 312-bp fragment from the N-terminus of VP5 encod-
ing residues 1 to 104 was amplified using error-pronePCR conditions as described by Svetlov and Cooper
(1998). The templates for the PCR reactions were pGBT9-
VP5 and pGBT9-PR7. The forward (AGTTGACTGTATCGC-
CGGAATTCA) primer contained an EcoRI site in its se-
quence and the 39 nucleotide corresponds to the A
nucleotide of the VP5 start codon. The first three nucle-
otides of the reverse primer (AATCAGCGGCTGGTGGAC-
CTCGAA) anneal to the DNA sequence encoding amino
acid 104 of UL19 (VP5) (McGeoch et al., 1988). Manga-
nese salts (MnSO4) were added to the PCR buffer to
reate base substitutions in the PCR product. The Mg
alt concentration in the PCR buffer was 2 mM (NEB,
everly, MA). Manganese was added at a concentration
f 0.5, 0.25 and 0.125 mM in the experiment. PCR reac-
ions were performed with 100 ng of linearized plasmid
NA. The reactions were carried out using Vent DNA
olymerase (NEB). The reaction mixtures were initially
ubjected to a denaturation step at 95°C for 5 min and
hen cycled 30 times; each cycle consisted of a 30-s
enaturation step at 94°C, followed by annealing at 55°C
or 30 s and extension at 72°C for 1 min. A final extension
t 72°C for 10 min was included. The PCR product was
igested with EcoRI and BspE1; the latter site spans
esidues 84–86 of VP5, and a 255-bp fragment encoding
esidues 1–85 was purified. An amount of 100–300 ng of
his DNA was ligated into pGBT9-VP5/PR7 vectors
reated with the same enzymes. The ligation mixture was
sed to transform Escherichia coli and an aliquot of the
ransformation was plated following 3 h of growth in
onselective medium. An amount of 300 ng of DNA insert
ave approximately 12,000 colonies in the transformation
ixture; therefore, mutations at each nucleotide (1–255)
hould be represented in this pool. Growth of the culture
as continued in selective medium (plus antibiotic) for
6 h; DNA was extracted from the remaining cells and
sed for transformation of yeast cells.
election of mutant clones
The pool of mutagenized pGBT9-VP5-PCR constructs
ith potential mutations were then cotransformed with
GAD424-22a into the yeast strain SFY526 and plated on
ynthetic medium (SD) plates lacking leucine and tryp-
ophan. Resulting single colonies were then assayed for
b-galactosidase activity on nitrocellulose filters using
X-gal (Breeden and Nasmyth, 1985). For KOS, colonies
that were white or light blue, indicating an elimination or
reduction of the interaction between VP5 and 22a, were
picked. In the PR7 mutagenesis experiment we were
looking for mutations that restored the interaction be-
tween the two proteins as measured by this assay, so we
chose colonies that were blue using the b-galactosidase
assay. PR7 VP5 normally gives white colonies when
cotransformed with 22a. Each chosen colony was re-
streaked on SD plates lacking leucine and tryptophan
and assayed again to confirm the initial result.
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315MUTATIONS IN VP5 OF HSV-1To specifically isolate just pGBT9 plasmids for se-
quence analysis, the yeast cells that tested a second
time for the desired reaction were grown in selective
medium that ensured segregation of the plasmids and
propagation of cells harboring the pGBT9 vectors. This
was done by growing the cells in SD medium lacking
only tryptophan and then plated on SD plates that also
lacked tryptophan. Single colonies from these plates
were then duplicate streaked onto SD plates that lacked
tryptophan or both leucine and tryptophan. We chose
streaks that grew on the plates that contained leucine,
but not on those lacking it. This allowed us to select for
colonies that retained the pGBT9-VP5 mutated plasmid
but had lost the pGAD424 plasmid. DNA was then iso-
lated from cultures of the selected yeast colonies and
transformed into E. coli (strain DH5a). Plasmid DNA was
solated from E. coli and sequenced.
Quantitative protein interaction assay
Selected pGBT9-VP5 mutant clones were cotrans-
formed with pGAD424-22a into SFY526 to quantitate the
levels of b-galactosidase expression. Quantitation was
essentially performed as described in Rose (Rose et al.,
1981) and Desai and Person (Desai and Person, 1996).
Site-directed mutagenesis
Site-directed mutations at residues 28 and 63 of VP5
were created by inverse PCR as described by Fisher and
Pei (1997). The UL19 (VP5) sequence spanning from the
start of translation (EcoRI site) to nucleotide 1290 (BamHI
site) was transferred from pGBT9-VP5 into pUC19. The
primers for mutation of residue 28 were 59-CTTAGCACGAT-
CAAGGTGGCGTCGCATC (forward) which started at nucle-
otide 70 of the UL19 ORF. The italicized base was changed
G3 A, which resulted in residue 28 being changed (E3
K) and also eliminated a PvuI site so that mutated clones
could be detected by a restriction digest. The reverse
primer for this reaction was 59-GAGGGACCCGGTCG-
GCACCATGGCCG where the 59 base was complementary
o nucleotide 69 of the UL19 ORF. Both of these primers
ere phosphorylated at the 59 end and extended in oppo-
ite directions so that the entire plasmid was amplified. The
CR reaction utilized a high fidelity enzyme, PfuTurbo (Strat-
gene, La Jolla, CA). The mutation at residue 63 was put in
y the same method, the primers were 59-GTCGTACTG-
AGCACCCTGTCGCTCG for the forward primer (the 59
ucleotide annealed to nucleotide 177 of UL19). Nucleotide
83 was changed from T to C and the nucleotide at 188
rom A to G. The change at nucleotide 188 incorporated the
esired mutation (N 3 S) and that change along with the
hange at 183 incorporated new PstI site. The latter change
id not change the amino acid sequence. The reverse
rimer was 59-CCCAGCAGGGCGTCGAACTCGACGTC (59
ase complementary to nucleotide 176 of UL19).
The PCR products were then ligated at RT for 2 h, cutith DpnI to remove the original plasmid template, and
ransformed into E. coli (strain DH5a). DNA fragments
were isolated from the plasmids that were shown by
restriction digest to contain the desired mutation and
cloned back into pGBT9-VP5 plasmid cut with EcoRI and
BamHI. Plasmid DNA was isolated and mutations in-
serted were confirmed by DNA sequencing.
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